News
-
-
-
COMMUNIQUÉ DE PRESSE
Rockhaven Reports Multiple High-Grade Vein Exposures at its Klaza Gold-Silver Project, Yukon
Rockhaven Resources Ltd. reports high-grade gold-silver assay results from the 2025 exploration program at Klaza property, Yukon, advancing towards potential bulk sampling and economic studies -
COMMUNIQUÉ DE PRESSE
DeFi Technologies Announces Leadership Transition: Olivier Roussy Newton Resigns as CEO and Chairman; Co-Founder Johan Wattenström Appointed as Successor
DeFi Technologies announces leadership transition as Olivier Roussy Newton resigns as CEO and Chairman; Johan Wattenström appointed as successor. Company's growth and milestones under Roussy Newton's leadership highlighted -
COMMUNIQUÉ DE PRESSE
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Jaguar Health, Inc. reports proof-of-concept trial shows crofelemer potential for MVID patients, financial results revealed, FDA meeting outcome, and upcoming investor webcast -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Medicus Pharma Ltd. announces FDA Commissioner's national priority voucher application for Skinject (SKNJCT-003) D-MNA to non-invasively treat BCC aligning with public health priorities and rare-disease needs
